Biotechnology: Pharmaceutical Preparations Stocks
436 biotechnology: pharmaceutical preparations stocks ranked by market capitalization, page 4 of 9. Updated October 11, 2026.
Today
+1.28%Biotechnology: Pharmaceutical Preparations stocks ranked 151–200
| # | Symbol | Company | Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| 151 | SPTX | Seaport Therapeutics Inc. | 18.15 | +1.34% | 171.21K | $971.58M |
| 152 | ANRO | Alto Neuroscience Inc. | 24.37 | +1.41% | 649.43K | $956.33M |
| 153 | KURA | Kura Oncology Inc. | 10.60 | +0.76% | 1.47M | $942.98M |
| 154 | ALMS | Alumis Inc. | 7.16 | +2.73% | 1.37M | $926.76M |
| 155 | MLTX | MoonLake Immunotherapeutics Class A | 10.82 | +2.27% | 2.01M | $920.85M |
| 156 | RIGL | Rigel Pharmaceuticals Inc. | 49.08 | +0.74% | 279.36K | $916.81M |
| 157 | JBIO | Jade Biosciences Inc. | 14.39 | +1.70% | 735.60K | $915.17M |
| 158 | CRVS | Corvus Pharmaceuticals Inc. | 10.52 | +3.04% | 1.03M | $884.95M |
| 159 | CYRX | CryoPort Inc. | 17.35 | +2.66% | 479.87K | $878.76M |
| 160 | HELP | Helus Pharma Inc. | 11.80 | +10.07% | 1.66M | $862.11M |
| 161 | ARDX | Ardelyx Inc. | 3.28 | +0.31% | 2.36M | $846.86M |
| 162 | AVBP | ArriVent BioPharma Inc. | 16.73 | +0.12% | 1.73M | $824.92M |
| 163 | OBX | Obsidian Therapeutics Inc. | 13.00 | +6.21% | 532.21K | $803.05M |
| 164 | GERN | Geron Corporation | 1.23 | +0.41% | 5.64M | $787.03M |
| 165 | IMMX | Immix Biopharma Inc. | 9.46 | +1.83% | 1.11M | $784.26M |
| 166 | APMD | Apnimed Inc. | 18.52 | +1.65% | 268.39K | $771.00M |
| 167 | ANNX | Annexon Inc. | 4.02 | +0.50% | 2.39M | $762.11M |
| 168 | VSTM | Verastem Inc. | 8.38 | +3.33% | 2.97M | $758.92M |
| 169 | LXRX | Lexicon Pharmaceuticals Inc. | 1.68 | -4.55% | 2.07M | $747.53M |
| 170 | GYRE | Gyre Therapeutics Inc. | 7.04 | +4.14% | 76.63K | $746.48M |
| 171 | IVA | Inventiva S.A. American Depository Shares | 3.16 | -4.82% | 2.79M | $746.46M |
| 172 | AVTX | Avalo Therapeutics Inc. | 13.65 | +1.64% | 648.58K | $732.05M |
| 173 | DSGN | Design Therapeutics Inc. | 11.65 | +1.39% | 356.59K | $729.08M |
| 174 | COLL | Collegium Pharmaceutical Inc. | 22.09 | -0.09% | 438.44K | $719.15M |
| 175 | PHAR | Pharming Group N.V. ADS | 9.79 | +2.73% | 3.33K | $692.92M |
| 176 | NVCT | Nuvectis Pharma Inc. | 21.12 | +4.92% | 152.96K | $689.44M |
| 177 | OLMA | Olema Pharmaceuticals Inc. | 7.82 | 0.00% | 758.25K | $684.23M |
| 178 | WVE | Wave Life Sciences Inc. | 3.46 | -0.29% | 1.66M | $681.79M |
| 179 | ZVRA | Zevra Therapeutics Inc. | 11.39 | +3.55% | 730.74K | $676.38M |
| 180 | FTH | Faeth Therapeutics Inc. | 26.03 | +1.64% | 197.16K | $672.63M |
| 181 | ABUS | Arbutus Biopharma Corporation | 4.22 | +0.96% | 3.15M | $646.82M |
| 182 | SGMT | Sagimet Biosciences Inc. Series A | 8.93 | +0.11% | 763.53K | $633.21M |
| 183 | CLYM | Climb Bio Inc. | 11.00 | +1.29% | 638.14K | $631.80M |
| 184 | IRWD | Ironwood Pharmaceuticals Inc. Class A | 3.82 | -1.29% | 1.72M | $631.22M |
| 185 | SLN | Silence Therapeutics Plc American Depository Share | 9.86 | +3.57% | 844.35K | $612.84M |
| 186 | AQST | Aquestive Therapeutics Inc. | 4.78 | +0.42% | 1.69M | $599.95M |
| 187 | STTK | Shattuck Labs Inc. | 5.97 | +5.48% | 1.05M | $599.17M |
| 188 | PHAT | Phathom Pharmaceuticals Inc. | 7.25 | +1.68% | 928.34K | $586.53M |
| 189 | CRMD | CorMedix Inc. | 7.38 | +0.82% | 1.19M | $575.23M |
| 190 | ACRS | Aclaris Therapeutics Inc. | 3.83 | +1.06% | 5.06M | $563.77M |
| 191 | CTMX | CytomX Therapeutics Inc. | 2.57 | +4.05% | 3.04M | $560.00M |
| 192 | BLSM | BlossomHill Therapeutics Inc. | 17.48 | +3.55% | 131.83K | $555.60M |
| 193 | CBIO | Crescent Biopharma Inc. | 14.91 | +5.59% | 347.15K | $553.86M |
| 194 | EVO | Evotec SE ADR | 1.53 | -2.55% | 40.01K | $543.75M |
| 195 | DRUG | Bright Minds Biosciences Inc. | 54.05 | +3.94% | 98.41K | $533.15M |
| 196 | PBYI | Puma Biotechnology Inc | 10.29 | +3.21% | 303.06K | $531.17M |
| 197 | MNPR | Monopar Therapeutics Inc. | 78.96 | -5.98% | 135.85K | $529.99M |
| 198 | NGNE | Neurogene Inc. | 26.40 | -0.38% | 465.90K | $528.30M |
| 199 | OCS | Oculis Holding AG | 8.34 | -3.70% | 162.06K | $513.64M |
| 200 | EOLS | Evolus Inc. | 7.73 | -0.90% | 430.13K | $510.57M |
Explore more
Prices as of Oct 11, 6:40 PM EDT. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer